SAN ANTONIO – An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR ...

“Liquid biopsies” make headlines for their potential to detect multiple cancers in their earliest stages, but it’s too soon to tell whether the tests are accurate and safe enough for widespread use, ...

Science News Virtual Diet and Exercise Program Can Help Reduce Side Effects of Lymphoma Treatment Patients who participated in the program had lower rates of anxiety, depression, pain and fatigue as ...

ORLANDO — Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as a mainstay of treatment for individuals living with ...

Joseph Unger, PhD, of Fred Hutchinson Cancer Center, and colleagues looked at data from the National Institutes of Health’s ClinicalTrials.gov registry from 2008 to 2024 to identify U.S. trials of ...

One day at the office, I developed a dull pain in my right lower abdomen that grew in intensity. I checked into the emergency room. My gallbladder was infected and had to come out. When I was in the ...

As federal and state funding for health programs shrinks, the Knight Cancer Institute at Oregon Health & Science University just hit the jackpot: A $2 billion donation from Nike cofounder Phil Knight, ...

Bone sarcoma, or primary bone cancer, originates in the bone tissue. It doesn’t include cancer that starts elsewhere in the body and spreads to the bones. Sarcomas also occur in soft connective ...

Mary Jane Minkin, MD, is codirector of the Sexuality, Intimacy & Menopause Program at Yale Medicine’s Smilow Cancer Hospital. She shares an encouraging message.

These results come on the heels of data presented at ASCO showing that another antibody-drug conjugate, Daiichi Sankyo and AstraZeneca’s Enhertu (fam-trastuzumab deruxtecan), improved progression-free ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

After a diagnosis of Stage IV prostate cancer, Euvon Jones turned his life around—with the help of his wife, Janet.